Literature DB >> 24889689

"Maybe they have found something new" participants' views on returning cohort psychosocial survey results.

Eve Bureau1,2,3, Isabelle Pellegrini1,2,3, Catherine Noguès4,5, Christine Lasset6, Claire Julian-Reynier1,2,3,7.   

Abstract

BACKGROUND: Although greater attention is currently being paid to participants in research, no studies have dealt so far with the issue of returning aggregate psychosocial results to cohort participants.
OBJECTIVE: (i) To explore participants' views about disclosure of the aggregate results of a French national psychosocial cohort survey on the epidemiology of preventive behaviour in women from families with a hereditary breast cancer risk. (ii) To assess whether it is worth consulting participants before designing the disclosure process.
DESIGN: A qualitative study using semi-structured face-to-face interviews and a thematic analysis based on Grounded Theory methods. PARTICIPANTS: Nineteen interviews were conducted with cancer-free female BRCA mutation carriers/non-carriers aged 31-79 who had participated in a cohort survey by answering self-administered questionnaires.
RESULTS: Participants showed considerable interest in the issue of result disclosure. The preferences expressed about disclosure were rarely relevant to the topic investigated, however, as they often focused on medical knowledge about BRCA and not on the psychosocial findings obtained. This confusion may have been due to the participants' experience of the survey procedures, including its longitudinal nature, the occurrence of very few interactions with the investigators and the wide range of topics addressed in the questionnaires.
CONCLUSION: Investigators should ascertain participants' expectations and preferences by consulting them before disclosing the results obtained. Although the disclosure process may not meet participants' expectations completely, consultation is the key to preventing them from having irrealistic expectations about the information they are going to receive.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  communicating research results; consultation; hereditary breast/ovarian cancer families; participants’ views; psychosocial cohort studies

Mesh:

Year:  2014        PMID: 24889689      PMCID: PMC5810700          DOI: 10.1111/hex.12211

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  32 in total

Review 1.  Disclosure of individual genetic data to research participants: the debate reconsidered.

Authors:  Annelien L Bredenoord; Hester Y Kroes; Edwin Cuppen; Michael Parker; Johannes J M van Delden
Journal:  Trends Genet       Date:  2010-12-27       Impact factor: 11.639

2.  Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

Authors:  Christine Maheu; Anne-Deborah Bouhnik; Catherine Nogues; Emmanuelle Mouret-Fourme; Dominique Stoppa-Lyonnet; Christine Lasset; Pascaline Berthet; Jean-Pierre Fricker; Olivier Caron; Elizabeth Luporsi; Laurence Gladieff; Claire Julian-Reynier
Journal:  Psychooncology       Date:  2013-10-11       Impact factor: 3.894

3.  Parental perceptions and attitudes about informed consent in clinical research involving children.

Authors:  S C Harth; Y H Thong
Journal:  Soc Sci Med       Date:  1995-12       Impact factor: 4.634

4.  Return of research results: general principles and international perspectives.

Authors:  Emmanuelle Lévesque; Yann Joly; Jacques Simard
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

5.  Offering to return results to research participants: attitudes and needs of principal investigators in the Children's Oncology Group.

Authors:  Conrad V Fernandez; Eric Kodish; Susan Shurin; Charles Weijer
Journal:  J Pediatr Hematol Oncol       Date:  2003-09       Impact factor: 1.289

6.  Phase 1 clinical trials in end-stage cancer: patient understanding of trial premises and motives for participation.

Authors:  Tove Godskesen; Peter Nygren; Karin Nordin; Mats Hansson; Ulrik Kihlbom
Journal:  Support Care Cancer       Date:  2013-07-18       Impact factor: 3.603

7.  Impact on survivors of retinoblastoma when informed of study results on risk of second cancers.

Authors:  Charlene J Schulz; Mary P Riddle; Heiddis B Valdimirsdottir; David H Abramson; Charles A Sklar
Journal:  Med Pediatr Oncol       Date:  2003-07

8.  Beyond "misunderstanding": written information and decisions about taking part in a genetic epidemiology study.

Authors:  Mary Dixon-Woods; Richard E Ashcroft; Clare J Jackson; Martin D Tobin; Joelle Kivits; Paul R Burton; Nilesh J Samani
Journal:  Soc Sci Med       Date:  2007-09-29       Impact factor: 4.634

9.  Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations.

Authors:  Claire Julian-Reynier; Julien Mancini; Emmanuelle Mouret-Fourme; Marion Gauthier-Villars; Valérie Bonadona; Pascaline Berthet; Jean-Pierre Fricker; Olivier Caron; Elisabeth Luporsi; Catherine Noguès
Journal:  Eur J Hum Genet       Date:  2011-01-26       Impact factor: 4.246

10.  The value of transnational medical research.

Authors:  Ann H Kelly; P Wenzel Geissler
Journal:  J Cult Econ       Date:  2011-02-28
View more
  1 in total

1.  Disclosure of research results: a randomized study on GENEPSO-PS cohort participants.

Authors:  Julien Mancini; Elodie Le Cozannet; Anne-Déborah Bouhnik; Noémie Resseguier; Christine Lasset; Emmanuelle Mouret-Fourme; Catherine Noguès; Claire Julian-Reynier
Journal:  Health Expect       Date:  2015-07-23       Impact factor: 3.377

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.